Mechanisms of antibiotic resistance and delivery strategies to prevent its emergence

Journal of Drug Delivery Science and Technology

Volumn 20, Issue 6, 2010, Pages 407-418

  Khoder, M ^a,b,c   Tsapis, N ^a,b   Fattal, E ^a,b  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b CNRS   (France)

^c University of Al Baath   (Syrian Arab Republic)

Author keywords

Antibiotics; Intestinal and colonic delivery; Resistance

Indexed keywords

ACTIVATED CARBON; AMYLOSE; ANTIBIOTIC AGENT; BETA LACTAMASE; CALCIUM ALGINATE; CHITOSAN; DEXTRAN; DRUG RESIDUE; ETHYL CELLULOSE; GUAR GUM; PECTIN; POLYMER; POLYSACCHARIDE; PROBIOTIC AGENT;

ANTIBIOTIC RESISTANCE; BACTERIAL COUNT; BACTERIAL GROWTH; BACTERIUM TRANSFORMATION; COMMENSAL; DRUG ABSORPTION; DRUG ADMINISTRATION ROUTE; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG INACTIVATION; DRUG TARGETING; GENE MUTATION; HUMAN; INTESTINE FLORA; NONHUMAN; PH; R FACTOR; REVIEW; TIMED DRUG RELEASE;

EID: 79551613052     PISSN: 17732247     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1773-2247(10)50072-8     Document Type: Review

References (136)

1. Yoneyama H., Katsumata R. -Antibiotic resistance in bacteria and its future for novel antibiotic development. - Biosci. Biotechnol. Biochem., 70, 1060-1075, 2006.
2. Levy S.B., Marshall B. - Antibacterial resistance worldwide: causes, challenges and responses. - Nat. Med., 10, S122-129, 2004.
3. Walsh C. - Antibiotics, Actions, Origins, Resistance. - ASM Press, Washington, DC, 2003.
4. Cohen M.L. - Changing patterns of infectious disease. - Nature, 406, 762-767, 2000.
5. Fauci A.S. - Infectious diseases: considerations for the 21st century. - Clin. Infect. Dis., 32, 675-685, 2001.
6. Nathan C. - Antibiotics at the crossroads. - Nature, 431, 899-902, 2004.
7. Levy S. - The Antibiotic Paradox: How Misuse of Antibiotics Destroys their Curative Powers. - Perseus, Cambridge, 2002.
8. van der Waaij D., Nord C.E. - Development and persistence of multi-resistance to antibiotics in bacteria; an analysis and a new approach to this urgent problem. - International Journal of Antimicrobial Agents, 16, 191-197, 2000.
9. Wright G.D., Sutherland A.D. - New strategies for combating multidrug-resistant bacteria. -Trends Mol. Med., 13, 260-267, 2007.
10. Ball A.R., Casadei G., Samosorn S., Bremner J.B., Ausubel F.M., Moy T.I., Lewis K. - Conjugating berberine to a multidrug efflux pump inhibitor creates an effective antimicrobial. - ACS Chem. Biol., 1, 594-600, 2006.
11. Sharma R., Sharma C.L., Kapoor B. - Antibacterial resistance: current problems and possible solutions. - Indian J. Med. Sci., 59, 120-129, 2005.
12. th ed., Oxford University Press, 2007.
13. Courvalin P. - Predictable and unpredictable evolution of antibiotic resistance. - J. Intern. Med., 264, 4-16, 2008.
14. Alonso A., Campanario E., Martinez J.L. - Emergence of multidrug-resistant mutants is increased under antibiotic selective pressure in Pseudomonas aeruginosa. - Microbiology-UK, 145, 2857-2862, 1999. (Pubitemid 29485900)
15. Andremont A. - Commensal flora may play key role in spreading antibiotic resistance. - Asm. News, 69, 601-607, 2003.
16. Hawkey P.M. - The origins and molecular basis of antibiotic resistance. - BMJ, 317, 657-660, 1998.
17. Salyers A.A., Moon K., Schlesinger D. - The human intestinal tract - a hotbed of resistance gene transfer? Part I. - Clin. Mic. Newsletter, 29, 2007.
18. Bennett P.M. - Plasmid encoded antibiotic resistance: acquisition and transfer of antibiotic resistance genes in bacteria. - Br. J. Pharmacol., 153, Suppl. 1, S347-357, 2008.
19. Lyon B.R., Skurray R.- Antimicrobial resistance of Staphylococcus aureus: genetic basis. - Microbiol. Rev., 51, 88-134, 1987.
20. Lorenz M.G., Wackernagel W. - Bacterial gene transfer by natural genetic transformation in the environment. - Microbiol. Rev., 58, 563-602, 1994.
21. Salyers A.A., Gupta A., Wang Y.P. - Human intestinal bacteria as reservoirs for antibiotic resistance genes. - Trends in Microbiology, 12, 412-416, 2004.
22. Licht T.R., Christensen B.B., Krogfelt K.A., Molin S. - Plasmid transfer in the animal intestine and other dynamic bacterial populations: the role of community structure and environment. - Microbiology-Sgm., 145, 2615-2622, 1999.
23. Kazimierczak K.A., Scott K.P. - Antibiotics and resistance genes: influencing the microbial ecosystem in the gut. - Adv. Appl. Microbiol., 62, 269-292, 2007.
24. Macfarlane S., Macfarlane G.T. - Composition and metabolic activities of bacterial biofilms colonizing food residues in the human gut. - Appl. Environ. Microbiol., 72, 6204-6211, 2006.
25. O'Connell H.A., Kottkamp G.S., Eppelbaum J.L., Stubblefield B.A., Gilbert S.E., Gilbert E.S. - Influences of biofilm structure and antibiotic resistance mechanisms on indirect pathogenicity in a model polymicrobial biofilm. - Appl. Environ. Microbiol., 72, 5013-5019, 2006.
26. Klieve A.V., Swain R.A. - Estimation of ruminai bacteriophage numbers by pulsed-field gel electrophoresis and laser densitometry. - Appl. Environ. Microbiol., 59, 2299-2303, 1993.
27. Cirz R.T., Chin J.K., Andes D.R., de Crecy-Lagard V., Craig W.A., Romesberg F.E. - Inhibition of mutation and combating the evolution of antibiotic resistance. - PLoS Biol. 3, e176, 2005.
28. Hastings P.J., Rosenberg S.M., Slack A. - Antibiotic-induced lateral transfer of antibiotic resistance. - Trends Microbiol., 12, 401-404, 2004.
29. Salyers A.A., Moon K., Schlessinger D. - The human intestinal tract - a hotbed of resistance gene transfer? Part II. - Clinical Microbiology Newsletter, 29, 4, 2007.
30. Sousa T., Paterson R., Moore V., Carlsson A., Abrahamsson B., Basit A.W. - The gastrointestinal microbiota as a site for the biotransformation of drugs. - Int. J. Pharm., 363, 1-25, 2008.
31. Cummings J.H., Antoine J.M., Azpiroz F., Bourdet-Sicard R., Brandtzaeg P., Calder P.C., Gibson G.R., Guarner F., Isolauri E., Pannemans D., Shortt C., Tuijtelaars S., Watzl B. - Pass-claim - Gut health and immunity. - Eur. J. Nutr., 43, Suppl. 2, 11118-11173, 2004.
32. Boyle R.J., Tang M.L. - Can allergic diseases be prevented prenatally? - Allergy, 61, 1423-1431, 2006.
33. Surawicz C.M. - Antibiotic-associated diarrhea and pseudomembranous colitis: are they less common with poorly absorbed antimicrobials? - Chemotherapy, 51, Suppl. 1, 81-89, 2005.
34. Vedantam G., Hecht D.W. - Antibiotics and anaerobes of gut origin. - Current Opinion in Microbiology, 6, 457-461, 2003.
35. Simon G.L., Gorbach S.L.- Intestinal flora in health and disease. - Gastroenterology, 86, 174-193, 1984.
36. Holzapfel W.H., Haberer P., Snel J., Schillinger U., Huis in't Veld J.H. - Overview of gut flora and probiotics. - Int. J. Food Microbiol., 41, 85-101, 1998.
37. Egert M., de Graaf A.A., Smidt H., de Vos W.M., Venema K. - Beyond diversity: functional microbiomics of the human colon. - Trends Microbiol., 14, 86-91, 2006.
38. Guarner F., Malagelada J.R. - Gut flora in health and disease. - Lancet, 361, 512-519, 2003.
39. Berg R.D. - The indigenous gastrointestinal microflora.-Trends Microbiol., 4, 430-435, 1996.
40. Edlund C., Nord C.E. - A model of bacterial-antimicrobial interactions: the case of oropharyngeal and gastrointestinal microflora. - J. Chemother., 3, Suppl. 1, 196-200, 1991.
41. Nord C.E., Heimdahl A., Kager L., Malmborg A.S. - The impact of different antimicrobial agents on the normal gastrointestinal microflora of humans. - Rev. Infect. Dis., 6, Suppl. 1, S270-275, 1984.
42. Finegold S.M. - Interaction of antimicrobial therapy and intestinal flora. - Am. J. Clin. Nutr., 23, 1466-1471, 1970.
43. Sullivan A., Edlund C., Nord C.E.- Effect of antimicrobial agents on the ecological balance of human microflora. - Lancet Infect. Dis., 1, 101-114, 2001.
44. McFarland L.V. - Alternative treatments for Clostridium difficile disease: what really works? - J. Med. Microbiol., 54, 101-111, 2005.
45. Dethlefsen L., Huse S., Sogin M.L., Relman D.A.-The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. - PLoS Biol., 6, e280, 2008.
46. de La Cochetiere M.P., Durand T., Lepage P., Bourreille A., Galmiche J.P., Dore J. - Resilience of the dominant human fecal microbiota upon short-course antibiotic challenge. - J. Clin. Microbiol., 43, 5588-5592, 2005.
47. Lindgren M., Lofmark S., Edlund C., Huovinen P., Jalava J. - Prolonged impact of a one-week course of clindamycin on Enterococcus spp. in human normal microbiota. - Scand. J. Infect. Dis., 41, 215-219, 2009.
48. Preidis G.A., Versalovic J. - Targeting the human microbiome with antibiotics, probiotics, and prebiotics: gastroenterology enters the metagenomics era. - Gastroenterology, 136, 2015-2031, 2009.
49. Monreal M.T., Pereira P.C., de Magalhaes Lopes C.A. - Intestinal microbiota of patients with bacterial infection of the respiratory tract treated with amoxicillin. - Braz. J. Infect. Dis., 9, 292-300, 2005.
50. Lode H., Von der Hoh N., Ziege S., Borner K., Nord C.E. - Ecological effects of linezolid versus amoxicillin/clavulanic acid on the normal intestinal microflora. - Scand. J. Infect. Dis., 33, 899-903, 2001.
51. Yan S.S., Gilbert J.M. - Antimicrobial drug delivery in food animals and microbial food safety concerns: an overview of in vitro and in vivo factors potentially affecting the animal gut microflora. - Adv. Drug Deliv. Rev., 56, 1497-1521, 2004.
52. Mizen L., Berry V., Woodnutt G. - The influence of uptake from the gastrointestinal tract and first-pass effect on oral bioavailability of (Z)-alkyloxyimino penicillins. - J. Pharm. Pharmacol., 47, 725-730, 1995.
53. Nord C.E. - The effect of antimicrobial agents on the ecology of the human intestinal microflora. - Veterinary Microbiology, 35, 193-197, 1993.
54. Sjovall J., Huitfeldt B., Magni L., Nord C.E.- Effect of beta-lactam prodrugs on human intestinal microflora. - Scand. J. Infect. Dis., Suppl. 49, 73-84, 1986.
55. Karachalios G., Charalabopoulos K. - Biliary excretion of antimicrobial drugs. - Chemotherapy, 48, 280-297, 2002.
56. Rubinstein E., Dautrey S., Farinoti R., St Julien L., Ramon J., Carbon C. - Intestinal elimination of Sparfloxacin, fleroxacin, and ciprofloxacin in rats. - Antimicrob. Agents Chemother., 39, 99-102, 1995.
57. Chandra R., Liu P., Breen J.D., Fisher J., Xie C., LaBadie R., Benner R.J., Benincosa L.J., Sharma A. - Clinical pharmacokinetics and gastrointestinal tolerability of a novel extended-release microsphere formulation of azithromycin. - Clin. Pharmacokinet., 46, 247-259, 2007.
58. Hoffman A., Horwitz E., Hess S., Cohen-Poradosu R., Kleinberg L., Edelberg A., Shapiro M. - Implications on emergence of antimicrobial resistance as a critical aspect in the design of oral sustained release delivery systems of antimicrobials. - Pharm. Res., 25, 667-671, 2008.
59. McFarland L.V. - Evidence-based review of probiotics for antibiotic-associated diarrhea and Clostridium difficile infections. - Anaerobe., 15, 274-280, 2009.
60. Courvalin P. - Antibiotic resistance: the pros and cons of probiotics. - Dig. Liver Dis., 38, Suppl. 2, S261-265, 2006.
61. Capozzi V., Spano G. - Horizontal gene transfer in the gut: is it a risk? - Food Research International, 42, 1501-1502, 2009.
62. Edlund C., Lindqvist L., Nord C.E. - Norfloxacin binds to human fecal material. - Antimicrob. Agents Chemother., 32, 1869-1874, 1988.
63. Bourgeois S., Laham A., Besnard M., Andremont A., Fattal E. - In vitro and in vivo evaluation of pectin beads for the colon delivery of beta-lactamases. - J. Drug Target., 13, 277-284, 2005.
64. Bourgeois S., Gernet M., Pradeau D., Andremont A., Fattal E. - Evaluation of critical formulation parameters influencing the bioactivity of beta-lactamases entrapped in pectin beads. - Int. J. Pharm., 324, 2-9, 2006.
65. Bourgeois S., Tsapis N., Honnas H., Andremont A., Shakweh M., Besnard M., Fattal E. - Colonic delivery of beta-lactamases does not affect amoxicillin pharmacokinetics in rats. - J. Pharm. Sci., 97, 1853-1863, 2008.
66. Khoder M., Tsapis N., Huguet H., Besnard M., Gueutin C., Fattal E. - Removal of ciprofloxacin in simulated digestive media by activated charcoal entrapped within zinc-pectinate beads. - Int. J. Pharm., 379, 251-259, 2009.
67. Chourasia M.K., Jain S.K. - Pharmaceutical approaches to colon targeted drug delivery systems. - J. Pharm. Pharm. Sci., 6, 33-66, 2003.
68. Rathbone M.J., Hadgraft J., Roberts M.S. - Modified-Release Drug Delivery Technology. - Marcel Dekker, 2003.
69. Yang L., Chu J.S., Fix J.A. - Colon-specific drug delivery: new approaches and in vitro/in vivo evaluation. - Int. J. Pharm., 235, 1-15, 2002.
70. Rubinstein A. - Colonic drug delivery. - Drug Discovery Today: Technologies, 2, 33-37, 2005.
71. Fix J. - Oral drug delivery, small intestine and colon. - In: Encyclopedia of Controlled Drug Delivery, Mathiowitz E. Ed., Wiley-Interscience Publication, New York, 1999, pp. 698-728.
72. Basit A.W. - Advances in colonic drug delivery. - Drugs, 65, 1991-2007, 2005.
73. Dew M.J., Hughes P.J., Lee M.G., Evans B.K., Rhodes J. - An oral preparation to release drugs in the human colon. - Br. J. Clin. Pharmacol., 14, 405-408, 1982.
74. Touitou E., Rubinstein A. - Targeted enteral delivery of insulin to rats. - Int. J. Pharm., 30, 95-99, 1986.
75. Thomas P., Richards D., Richards A., Rogers L., Evans B.K., Dew M.J., Rhodes J. - Absorption of delayed-release prednisolone in ulcerative colitis and Crohn's disease. - J. Pharm. Pharmacol., 37, 757-758, 1985.
76. Van Saene J.J., Van Saene H.K., Geitz J.N., Tarko-Smit N.J., Lerk C.F. - Quinolones and colonization resistance in human volunteers. - Pharm Weekbl Sci., 8, 67-71, 1986.
77. Mardini H.A., Lindsay D.C., Deighton C.M., Record C.O. - Effect of polymer coating on faecal recovery of ingested 5-amino salicylic acid in patients with ulcerative colitis. - Gut, 28, 1084-1089, 1987.
78. Levine D.S., Raisys V.A., Ainardi V. - Coating of oral beclomethasone dipropionate capsules with cellulose acetate phthalate enhances delivery of topically active antiinflammatory drug to the terminal ileum. - Gastroenterology, 92, 1037-1044, 1987.
79. Hardy J.G., Healey J.N., Reynolds J.R. - Evaluation of an entericcoated delayed-release 5-aminosalicylic acid tablet in patients with inflammatory bowel disease. - Aliment. Pharmacol. Ther., 1, 273-280, 1987.
80. McConnell E.L., Fadda H.M., Basit A.W.-Gut instincts: explorations in intestinal physiology and drug delivery. - Int. J. Pharm., 364, 213-226, 2008.
81. Evans D.F., Pye G., Bramley R., Clark A.G., Dyson T.J., Hardcastle J.D. - Measurement of gastrointestinal pH profiles in normal ambulant human subjects. - Gut, 29, 1035-1041, 1988.
82. Ibekwe V.C., Fadda H.M., McConnell E.L., Khela M.K., Evans D.F., Basit A.W. - Interplay between intestinal pH, transit time and feed status on the in vivo performance of pH responsive ileo-colonic release systems. - Pharm. Res., 25, 1828-1835, 2008.
83. Ibekwe V.C., Liu F., Fadda H.M., Khela M.K., Evans D.F., Parsons G.E., Basit A.W. - An investigation into the in vivo performance variability of pH responsive polymers for ileo-colonic drug delivery using gamma scintigraphy in humans. - J. Pharm. Sci., 95, 2760-2766, 2006.
84. Cheng G., An F., Zou M.J., Sun J., Hao X.H., He Y.X. - Time- and pH-dependent colon-specific drug delivery for orally administered diclofenac sodium and 5-aminosalicylic acid. - World J. Gastroenterol., 10, 1769-1774, 2004.
85. Hu Z., Shimokawa T., Ohno T., Kimura G., Mawatari S.S., Kamitsuna M., Yoshikawa Y., Masuda S., Takada K. - Characterization of norfloxacine release from tablet coated with a new pH-sensitive polymer, P-4135F. - J. Drug Target., 7, 223-232, 1999.
86. Ibekwe V.C., Fadda H.M., Parsons G.E., Basit A.W. - A comparative in vitro assessment of the drug release performance of pH-responsive polymers for ileo-colonic delivery. - Int. J. Pharm., 308, 52-60, 2006.
87. Iruin A., Fernandez-Arevalo M., Alvarez-Fuentes J., Fini A., Holgado M.A. - Elaboration and "in vitro" characterization of 5-ASA beads. - Drug Dev. Ind. Pharm., 31, 231-239, 2005.
88. Rudolph M.W., Klein S., Beckert T.E., Petereit H., Dressman J.B. - A new 5-aminosalicylic acid multi-unit dosage form for the therapy of ulcerative colitis. - Eur. J. Pharm. Biopharm., 51, 183-190, 2001.
89. Gao C., Huang J., Jiao Y., Shan L., Liu Y., Li Y., Mei X. - In vitro release and in vivo absorption in beagle dogs of meloxicam from Eudragit FS 30 D-coated pellets. - Int. J. Pharm., 322, 104-112, 2006.
90. McConnell E.L., Short M.D., Basit A.W. - An in vivo comparison of intestinal pH and bacteria as physiological trigger mechanisms for colonic targeting in man. - J Control. Rel., 130, 154-160, 2008.
91. Qiu Y., Chen Y., Zhang G.G.Z., Liu L., Porter W. - Developing Solid Oral Dosage Forms: Pharmaceutical Theory & Practice. - Elsevier, 2009.
92. Kumar P., Mishra B. - Colon targeted drug delivery systems, an overview. - Curr. Drug Deliv., 5, 186-198, 2008.
93. Wilding I.R., Davis S.S., Bakhshaee M., Stevens H.N., Sparrow R.A., Brennan J. - Gastrointestinal transit and systemic absorption of captopril from a pulsed-release formulation. - Pharm. Res., 9, 654-657, 1992.
94. Hebden J.M., Wilson C.G., Spiller R.C., Gilchrist P.J., Blackshaw E., Frier M.E., Perkins A.C. - Regional differences in quinine absorption from the undisturbed human colon assessed using a timed release delivery system. - Pharm. Res., 16, 1087-1092, 1999.
95. F. Pozzi P.F., A. Gazzaniga, S.S. Davis, I.R. Wilding - The time clock system: a new oral dosage form for fast and complete release of drug after a predetermined lag time. - J. Control. Rel., 31, 99-108, 1994.
96. Adkin D.A., Kenyon C.J., Lerner E.I., Landau I., Strauss E., Caron D., Penhasi A., Rubinstein A., Wilding I.R. -The use of scintigraphy to provide "proof of concept" for novel polysaccharide preparations designed for colonic drug delivery. - Pharm. Res., 14, 103-107, 1997.
97. Qi M., Wang P., Wu D. - A novel pH- and time-dependent system for colonic drug delivery. - Drug Dev. Ind. Pharm., 29, 661-667, 2003.
98. Gupta V.K., Beckert T.E., Price J.C. - A novel pH- and time-based multi-unit potential colonic drug delivery system. I. Development. - Int. J. Pharm., 213, 83-91, 2001.
99. Fukui E., Miyamura N., Uemura K., Kobayashi M. - Preparation of enteric coated timed-release press-coated tablets and evaluation of their function by in vitro and in vivo tests for colon targeting. - Int. J. Pharm., 204, 7-15, 2000.
100. Akhgari A., Sadeghi F., Garekani H.A. - Combination of time-dependent and pH-dependent polymethacrylates as a single coating formulation for colonic delivery of indomethacin pellets. - Int. J. Pharm., 320, 137-142, 2006.
101. Zheng W., McGinity J.W. - Influence of Eudragit NE 30 D blended with Eudragit L 30 D-55 on the release of phenylpropanolamine hydrochloride from coated pellets. - Drug Dev. Ind. Pharm., 29, 357-366, 2003.
102. Munday D.L. - Film coated pellets containing verapamil hydrochloride: enhanced dissolution into neutral medium. - Drug Dev. Ind. Pharm., 29, 575-583, 2003.
103. Mastiholimath V.S., Dandagi P.M., Jain S.S., Gadad A.P., Kulkarni A.R. -Time and pH dependent colon specific, pulsatile delivery of theophylline for nocturnal asthma.- Int. J. Pharm., 328, 49-56, 2007.
104. Bassotti G., Gaburri M. - Manometric investigation of high-amplitude propagated contractile activity of the human colon. - Am. J. Physiol., 255, G660-664, 1988.
105. Takaya T., Ikeda C., Imagawa N., Niwa K., Takada K. - Development of a colon delivery capsule and the pharmacological activity of recombinant human granulocyte colony-stimulating factor (rhG-CSF) in beagle dogs. - J. Pharm. Pharmacol., 47, 474-478, 1995.
106. Muraoka M., Hu Z., Shimokawa T., Sekino S., Kurogoshi R., Kuboi Y., Yoshikawa Y., Takada K. - Evaluation of intestinal pressure-controlled colon delivery capsule containing caffeine as a model drug in human volunteers. - J. Control. Rel., 52, 119-129, 1998.
107. Hu Z., Kimura G., Mawatari S., Shimokawa T., Yoshikawa Y., Takada K. - New preparation method of intestinal pressure-controlled colon delivery capsules by coating machine and evaluation in beagle dogs. - J. Control. Rel., 56, 293-302, 1998.
108. Sinha V.R., Kumria R. - Microbially triggered drug delivery to the colon. - Eur. J. Pharm. Sci., 18, 3-18, 2003.
109. Scheline R.R. - Metabolism of foreign compounds by gastrointestinal microorganisms. - Pharmacol. Rev., 25, 451-523, 1973.
110. Peppercorn M.A., Goldman P. -The role of intestinal bacteria in the metabolism of salicylazosulfapyridine. - J. Pharmacol. Exp. Ther., 181, 555-562, 1972.
111. Singh B.N. - Modified-release solid formulations for colonic delivery. - Recent Pat. Drug Deliv. Formul., 1, 53-63, 2007.
112. Sinha V.R., Kumria R. - Polysaccharides in colon-specific drug delivery. - Int. J. Pharm., 224, 19-38, 2001.
113. Liu L., Fishman M.L., Hicks K.B., Kende M., Ruthel G. - Pectin/zein beads for potential colon-specific drug delivery: synthesis and in vitro evaluation. - Drug Deliv., 13, 417-423, 2006.
114. Nunthanid J., Huanbutta K., Luangtana-Anan M., Sriamornsak P., Limmatvapirat S., Puttipipatkhachorn S. - Development of time-, pH-, and enzyme-controlled colonic drug delivery using spray-dried chitosan acetate and hydroxypropyl methylcellulose. - Eur. J. Pharm. Biopharm., 68, 253-259, 2008.
115. Nunthanid J., Luangtana-anan M., Sriamornsak P., Limmatvapirat S., Huanbutta K., Puttipipatkhachorn S. - Use of spray-dried chitosan acetate and ethylcellulose as compression coats for colonic drug delivery: effect of swelling on triggering in vitro drug release. - Eur. J. Pharm. Biopharm., 71, 356-361, 2009.
116. McConnell E.L., Tutas, J., Mohamed, M.A.M., Banning, D., Basit, A.W. - Colonic drug delivery using amylose films: the role of aqueous ethylcellulose dispersions in controlling drug release. - Cellulose, 14, 25-34, 2007.
117. Tozaki H., Komoike J., Tada C., Maruyama T., Terabe A., Suzuki T., Yamamoto A., Muranishi S. - Chitosan capsules for colonspecific drug delivery: improvement of insulin absorption from the rat colon. - J. Pharm. Sci., 86, 1016-1021, 1997.
118. Rubinstein A., Nakar D., Sintov A. - Colonic drug delivery: enhanced release of indomethacin from cross-linked chondroitin matrix in rat cecal content. - Pharm. Res., 9, 276-278, 1992.
119. Ashford M., Fell, J.T., Attwood, D., Sharma, H.L. Woodhead, P.J., - Studies on pectin formulation for colonic drug delivery. - J. Control. Rel., 30, 225-232, 1994.
120. Ashford M., Fell, J.T., Attwood, D., Sharma, H.L. Woodhead, P.J., - An evaluation of pectin as a carrier for drug targeting to the colon. - J. Control. Rel., 26, 213-220., 1993.
121. Ahrabi S.F., Madsen G., Dyrstad K., Sande S.A., Graffner C. - Development of pectin matrix tablets for colonic delivery of model drug ropivacaine. - Eur. J. Pharm. Sci., 10, 43-52, 2000.
122. Lin S.Y., Ayres J.W. - Calcium alginate beads as core carriers of 5-aminosalicylic acid. - Pharm. Res., 9, 1128-1131, 1992.
123. Chiu H.C., Hsiue G.H., Lee Y.P., Huang L.W. - Synthesis and characterization of pH-sensitive dextran hydrogels as a potential colon-specific drug delivery system. - J. Biomater. Sci. Polym. Ed., 10, 591-608, 1999.
124. Kenyon C.J., Nardi R.V., Wong D., Hooper G., Wilding I.R., Friend D.R. - Colonic delivery of dexamethasone: a pharmacoscintigraphic evaluation. - Aliment. Pharmacol. Ther., 11, 205-213, 1997.
125. Milojevic S., Newton, J.M., Cummings, J.H., Gibson, G.R., Botham, R.L., Ring, S.G.., Stockham M., Allwood, M.C., - Amylose as a coating for drug delivery to the colon: preparation and in vitro evaluation using 5-aminosalicylic acid pellets. - J. Control. Rel., 38, 75-84, 1996.
126. Harmoinen J., Vaali K., Koski P., Syrjanen K., Laitinen O., Lindevall K., Westermarck E. - Enzymic degradation of a beta-lactam antibiotic, ampicillin, in the gut: a novel treatment modality. - J. Antimicrob. Chemother., 51, 361-365, 2003.
127. Harmoinen J., Mentula S., Heikkila M., van der Rest M., Rajala-Schultz P.J., Donskey C.J., Frias R., Koski P., Wickstrand N., Jousimies-Somer H., Westermarck E., Lindevall K. - Orally administered targeted recombinant Beta-lactamase prevents ampicillin-induced selective pressure on the gut microbiota: a novel approach to reducing antimicrobial resistance. - Antimicrob. Agents Chemother., 48, 75-79, 2004.
128. Stiefel U., Harmoinen J., Koski P., Kaariainen S., Wickstrand N., Lindevall K., Pultz N.J., Bonomo R.A., Helfand M.S., Donskey C.J. - Orally administered recombinant metallo-beta-lactamase preserves colonization resistance of piperacillin-tazobactam-treated mice. - Antimicrob. Agents Chemother., 49, 5190-5191, 2005.
129. Stiefel U., Pultz N.J., Harmoinen J., Koski P., Lindevall K., Helfand M.S., Donskey C.J. - Oral administration of beta-lactamase preserves colonization resistance of piperacillin-treated mice. - J. Infect. Dis., 188, 1605-1609, 2003.
130. Tarkkanen A.M., Heinonen T., Jogi R., Mentula S., van der Rest M.E., Donskey C.J., Kemppainen T., Gurbanov K., Nord C.E. - P1A recombinant beta-lactamase prevents emergence of antimicrobial resistance in gut microflora of healthy subjects during intravenous administration of ampicillin. - Antimicrob. Agents Chemother., 53, 2455-2462, 2009.
131. Luessen H.L., Verhoef J.C., Borchard G., Lehr C.M., de Boer A.G., Junginger H.E. - Mucoadhesive polymers in peroral peptide drug delivery. II. Carbomer and polycarbophil are potent inhibitors of the intestinal proteolytic enzyme trypsin. - Pharm. Res., 12, 1293-1298, 1995.
132. Gockel A.B.-S.a.N.C. - Development and analysis of a polymer protecting from luminal enzymatic degradation caused by a-chymotrypsin. - Int. J. Pharm., 146, 247-254 1997.
133. Ramon J., Dautrey S., Farinoti R., Carbon C., Rubinstein E. - Intestinal elimination of ciprofloxacin in rabbits. - Antimicrob. Agents Chemother., 38, 757-760, 1994.
134. Fantin B., Duval X., Massias L., Alavoine L., Chau F., Retout S., Andremont A., Mentre F. - Ciprofloxacin dosage and emergence of resistance in human commensal bacteria. - J. Infect. Dis., 200, 390-398, 2009.
135. Harder S., Fuhr U., Beermann D., Staib A.H. - Ciprofloxacin absorption in different regions of the human gastrointestinal tract. Investigations with the hf-capsule. - Br. J. Clin. Pharmacol., 30, 35-39, 1990.
136. Khoder M., Tsapis N., Domergue-Dupont V., Gueutin C., Fattal E. - Removal of residual colonic ciprofloxacin in the rat by activated charcoal entrapped within zinc pectinate beads. - Eur. J. Pharm. Sci., 41, 281-288, 2010.